Literature DB >> 722729

Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids.

J H Greenberg, A Mellors, J C McGowan.   

Abstract

The ability of a number of lipophilic compounds to inhibit the mouse-brain synaptosomal enzyme acyl coenzyme A:lysophosphatidylcholine acyltransferase has been measured in vitro. Psychoactive cannabinoids inhibit the enzyme at concentrations much lower than is predicted from their capacity to act as lipid-soluble anesthetics. Nonpsychoactive cannabinoids do not show specific inhibition. Molar volume relationships are used to show that, while all lipid-soluble molecules exert some inhibitory effect in proportion to their ability to dissolve in biological membranes, psychoactive cannabinoids have an inhibitory effect greatly in excess of their anesthetic potency. The isoprenoid convulsant thujone has been suggested to have psychoactivity similar to cannabinoids but does not mimic the cannabinoids in inhibiting the synaptosomal enzyme. Molar volumes and specific interactions are used in structure-activity correlations which yield information on the relative concentrations of biophase in drug-responsive systems and the specificity of membrane-active drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 722729     DOI: 10.1021/jm00210a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Effect of delta 9-tetrahydrocannabinol and merthiolate on acyltransferase activities in guinea pig liver microsomes.

Authors:  K Badiani; X Lu; G Arthur
Journal:  Lipids       Date:  1993-04       Impact factor: 1.880

Review 2.  Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development.

Authors:  Charu Sharma; Bassem Sadek; Sameer N Goyal; Satyesh Sinha; Mohammad Amjad Kamal; Shreesh Ojha
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.